Polfa Tarchomin plans change
Andrzej Kleszczewski who has headed pharmaceutical producer Polfa Tarchomin only for twenty days now, has already planned a restructuring plan for the company which will be made public on 17 February.
Polfa will be buying licences to produce certain products which, he hopes, will increase market share by around 15 percent. The company is heavily in debt although it is also has a lot of outstanding invoices to hospitals which it has difficulties collecting. Nonetheless Kleszczewski claims that the company has not lost liquidity.